Blue Horizon Enterprise Ltd 4
4 · Stoke Therapeutics, Inc. · Filed Dec 27, 2024
Insider Transaction Report
Form 4
Skorpios Trust
10% Owner
Transactions
- Sale
Common Stock
2024-12-23$11.50/sh−2,000,000$23,000,000→ 6,906,181 total(indirect: See Footnote)
Footnotes (1)
- [F1]Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,967,621 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 3,938,560 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.